Press release
Platelet Aggregation Inhibitors Market to Surge at a Robust Pace by 2027
Platelet are blood cells, which make up small volume of the blood and prevents bleeding. Platelet-aggregation inhibiting drugs prevent blood clot inside of the body as during atherosclerosis. Platelet aggregation inhibitors are antiplatelet drugs prescribed during coronary artery diseases, chest pain, stroke, periphery artery disease (PAD), etc. It is also used during heart bypass surgery, atrial fibrillation, after angioplasty and stent placement. Platelet aggregation is the biological process, mediated by PAF (platelet activation factor). Platelet aggregation inhibitors are used during thrombocytosis that occur during hematologic diseases, cancer, and other chronic infections. Aspirin, antiplatelet drug is most commonly used as it changes the balance between prostacyclin and thromboxane, antiplatelet drug inhibits enzyme cyclooxygenase, which reduces prostacyclin in vascular endothelial cells and thromboxane synthesis in platelet.Major cause of platelet aggregation are high triglycerides, lack of exercise, improper diet and sedentary lifestyle. Research scientists have turned to technologically advanced technique for increased efficacy of platelet aggregation inhibitor drugs that reflects positive growth of the Platelet Aggregation Inhibitor Market. Many heart and stroke patients are treated by dual antiplatelet therapy using two types of antiplatelet agents known as aspirin and P2Y12 inhibitor.
Platelet aggregation test is performed before prescribing anticoagulants, as it helps to determine the platelet clotting efficiency, some platelet aggregation cause serious problems and contribute to cardiovascular diseases. Patients with diabetes and high cholesterol (hypercholesterolemia) demonstrate increased platelet aggregation capacity and expose them to clotting disorders followed by vessel obstruction and thrombus. Hypercholesterolaemia (high cholesterol) is one of the major cause of death globally, about 2.6 million death occur per year worldwide. According to world health organization, in the European Union five biggest countries - Germany, France, Italy, Spain and UK, 133 million people suffer from bad cholesterol. New generation platelet aggregation inhibitors are more rapid in action with increased absorption with improved efficacy which will drive the growth of the platelet aggregation inhibitor market in the near future.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25946
Factors such as increased risk of cardiovascular diseases, technological advancements in the development of platelet aggregation inhibitor drugs, increase in clinical studies due to potent platelet aggregation inhibitor drug candidates in the pipeline, cost effective drugs and increased expenditure on healthcare sector are some of the factors fuelling the growth of the global platelet aggregation inhibitor market. Some factors such as unfavorable healthcare reforms, lack of awareness and skilled professionals, patent expiration, high development cost are some factors inhibiting the growth of target market.
The platelet aggregation inhibitor market is segment based on application, route of administration distribution channel and geography. Based on the application type, the platelet aggregation inhibitor market is segmented into venous thromboembolism (VTE), acute coronary syndrome/ myocardial infarction, and atrial fibrillation (AF). On the basis of route of administration, the platelet aggregation inhibitor market is segmented into injection and oral. Based on distribution channel, the platelet aggregation inhibitor market is segmented into hospital pharmacy, retail pharmacy, drug stores, and online pharmacy. Increase in the number of patient population and lifestyle diseases will boost the platelet aggregation inhibitors market. Growth opportunities such as increasing market share through mergers and acquisitions, investing in emerging economics, technological advancement and patent expiration will facilitate the small players to develop generic version of platelet aggregation inhibitor drugs that will boost the growth of the platelet aggregation inhibitor market.
Some of the key players in global platelet aggregation inhibitor market are Sanofi S.A., Bristol-Myers Squibb, Pfizer Inc., Bayer AG, Otsuka Pharmaceutical Co., Ltd., Boehringer Ingelheim, Eli Lilly and Company, Johnson & Johnson, Genentech, Inc., DAIICHI SANKYO COMPANY, LIMITED, AstraZeneca plc. and others
View Report -
https://www.transparencymarketresearch.com/platelet-aggregation-inhibitors-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Platelet Aggregation Inhibitors Market to Surge at a Robust Pace by 2027 here
News-ID: 1121331 • Views: …
More Releases from Transparency Market Research
Polypropylene Catalyst Market: Transforming Polymer Manufacturing Through Effici …
The global polypropylene catalyst market is entering a period of sustained expansion, driven by rising polypropylene (PP) consumption across automotive, packaging, consumer goods, and industrial applications. With the market projected to reach US$ 1.7 Bn by 2031, the strategic importance of catalysts-core enablers of higher yield, improved polymer performance, and process efficiency-is becoming more pronounced. Catalyst innovations are redefining PP production economics and helping manufacturers align with sustainability and circular…
Virtual Power Plant (VPP) Market Outlook 2035: Growth Dynamics, Revenue Forecast …
The global virtual power plant (VPP) market is undergoing a transformative expansion driven by the rapid integration of distributed energy resources (DERs), the global shift toward renewable power, and the rising need for grid flexibility. Valued at US$ 3.4 billion in 2024, the market is forecast to reach US$ 28.6 billion by 2035, exhibiting an impressive CAGR of 21.3% from 2025 to 2035. As energy systems evolve toward decentralized and…
POP Display Market Outlook 2031: Retail Transformation, Visual Merchandising Inn …
The global POP (Point-of-Purchase) display market continues to evolve as brands intensify competition for consumer attention across retail environments. Valued at US$ 10.2 Bn in 2022, the industry is forecast to grow at a substantial CAGR of 8.4% from 2023 to 2031, ultimately reaching US$ 19.5 Bn by 2031. POP displays have become one of the most effective in-store marketing tools, enabling retailers and manufacturers to influence buying decisions at…
Pore Strips Market Outlook 2031: Rising Skincare Awareness and Blackhead Removal …
The global pore strips market continues to expand steadily as consumers increasingly prioritize convenient, low-cost skincare solutions. The market was valued at US$ 1.4 Bn in 2022 and is projected to grow at a CAGR of 5.8% from 2023 to 2031, ultimately reaching US$ 1.8 Bn by 2031. Pore strips-adhesive-based skincare products designed to remove blackheads, excess sebum, dead skin, and impurities-have grown immensely popular among men and women alike.…
More Releases for Platelet
Key Trend Reshaping the Platelet Aggregation Devices Market in 2025: Innovative …
What industry-specific factors are fueling the growth of the platelet aggregation devices market?
The increasing prevalence of target diseases is anticipated to drive the growth of the platelet aggregation devices market. Target diseases, such as cancer, cardiovascular diseases, and diabetes, significantly impact public health and are a primary focus for prevention and treatment. Platelet aggregation devices aid in early detection and management of thrombotic risks, preventing complications like heart attacks and…
Prominent Platelet Aggregation Devices Market Trend for 2025: Innovative Platele …
What Are the Projected Growth and Market Size Trends for the Platelet Aggregation Devices Market?
Over the past few years, there has been a remarkable growth in the market size of platelet aggregation devices. The market is estimated to expand from $0.83 billion in 2024 to $1.05 billion in 2025, reflecting a compound annual growth rate (CAGR) of 25.8%. The historic period growth is mainly due to factors such as…
Platelet Aggregation Devices Market Report 2024 - Platelet Aggregation Devices M …
"The Business Research Company recently released a comprehensive report on the Global Platelet Aggregation Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Platelet Agitators Market Size 2024 to 2031.
Market Overview and Report Coverage
A Platelet Agitator is a device used in blood banks and clinical laboratories to store and agitate platelets at controlled temperature and agitation. Platelets are fragile blood cells that play a crucial role in blood clotting and must be stored properly to maintain their viability.
The Platelet Agitators Market is expected to witness robust growth in the coming years, with a projected CAGR of 12.50%…
Platelet Aggregation Devices Market - Empowering Precision Care: Unleashing the …
Newark, New Castle, USA - new report, titled Platelet Aggregation Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Platelet Aggregation Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Platelet Aggregation Devices market. The report offers an overview of…
Platelet Rich Plasma (PRP) Market By Product Type (Pure Platelet Rich Plasma, Pu …
The "Platelet Rich Plasma (PRP) Market)" research report profiles market participants and discusses their product offerings, revenues, SWOT analyses, and Porter's Five Forces Analysis to provide information about the current market competition. The greatest revenue share in 2022 will be accounted for by the Platelet Rich Plasma (PRP) Industry. based on types, applications, and geographical regions. The global market's major trends are included in the Platelet Rich Plasma (PRP) market…
